Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Conducting Physical Stability Studies on Emulsions

Posted on By

SOP for Conducting Physical Stability Studies on Emulsions

Conducting Physical Stability Studies on Emulsions

1) Purpose

The purpose of this SOP is to describe the process for conducting physical stability studies on emulsions. Physical stability is essential to ensure that emulsions maintain their homogeneity, droplet size distribution, and absence of phase separation over time under various storage conditions. This helps establish the shelf life and suitability of emulsions for commercial or clinical use.

2) Scope

This SOP applies to personnel involved in the formulation, testing, and quality control of emulsion-based products. It covers the preparation, evaluation, and testing of emulsions to monitor droplet size distribution, zeta potential, viscosity, and visual signs of instability such as creaming, coalescence, or phase separation.

3) Responsibilities

  • Formulation Scientists: Responsible for preparing emulsions for stability testing and ensuring all necessary documentation is completed.
  • QC Team: Responsible for conducting physical stability tests, including droplet size analysis and visual inspection, and documenting results.
  • QA Team: Responsible for reviewing stability study results and ensuring compliance with regulatory guidelines and good manufacturing practices (GMP).
See also  SOP for Freeze-Thaw Stability Testing of Liposome Formulations

4) Procedure

4.1 Preparation for Stability Testing

  • 4.1.1 Prepare sufficient quantities of the emulsion for stability testing and ensure uniformity across all test samples.
  • 4.1.2 Store the emulsions in sterile, sealed containers, labeled with batch number, preparation date, and storage conditions.
  • 4.1.3 Divide the samples into groups for different storage conditions, such as refrigerated (4°C), room temperature (25°C), and accelerated conditions (40°C), as required by the protocol.

4.2 Key Parameters for Physical Stability

The following parameters must be monitored during physical stability studies:

  • 4.2.1 Droplet Size Distribution: Use dynamic light scattering (DLS) or laser diffraction techniques to measure droplet size distribution. Track any significant changes in droplet size over time.
  • 4.2.2 Zeta Potential: Measure the zeta potential to assess the colloidal stability of the emulsion. A high absolute zeta potential typically indicates better physical stability.
  • 4.2.3 Viscosity: Measure the viscosity of the emulsion at regular intervals using a viscometer. Changes in viscosity may indicate instability or phase separation.
  • 4.2.4 Visual Inspection: Regularly inspect the emulsion for signs of instability, including creaming, sedimentation, phase separation, or coalescence.
See also  SOP for Microfluidization Technique for Liposome Preparation

4.3 Sampling and Testing Time Points

  • 4.3.1 Initial Tests: Conduct an initial assessment of the emulsion immediately after preparation, including droplet size analysis, zeta potential, and visual inspection.
  • 4.3.2 Interim Tests: Perform stability tests at regular intervals (e.g., 1 month, 3 months, 6 months) for emulsions stored at different conditions.
  • 4.3.3 Final Test: Conduct the final assessment at the end of the stability study period (e.g., 12 months).

4.4 Data Recording and Analysis

  • 4.4.1 Record all test results in the Stability Test Report (see Annexure 1 for the template).
  • 4.4.2 Analyze the data to identify any trends in physical stability, such as droplet size increase, zeta potential reduction, or viscosity changes.
  • 4.4.3 Compare stability under different storage conditions to determine the optimal storage environment for the emulsion.

4.5 Stability Criteria

The emulsion is considered physically stable if it meets the following criteria throughout the stability study:

  • 4.5.1 Droplet size remains within the acceptable range (as defined by the formulation protocol) with no significant increase.
  • 4.5.2 Zeta potential remains within the range that indicates good colloidal stability (typically ±30 mV or higher).
  • 4.5.3 No significant changes in viscosity or signs of creaming, sedimentation, or phase separation.
See also  SOP for Preparation of Sterically Stabilized Liposomes

5) Abbreviations, if any

  • DLS: Dynamic Light Scattering
  • QC: Quality Control
  • QA: Quality Assurance

6) Documents, if any

  • Batch Manufacturing Record (BMR)
  • Stability Test Report
  • Droplet Size Analysis Report
  • Zeta Potential Report
  • Viscosity Measurement Report

7) References, if any

  • ICH Q1A: Stability Testing of New Drug Substances and Products
  • FDA Guidelines for Stability Testing of Emulsion Drug Products

8) SOP Version

Version 1.0

Annexure

Annexure 1: Stability Test Report Template

Time Point Storage Condition Droplet Size (nm) Zeta Potential (mV) Viscosity (cP) Visual Inspection Operator Initials
Initial 4°C 100-200 nm -30 to -50 mV 10 cP No creaming Operator Name
1 Month 25°C 100-200 nm -30 to -50 mV 10 cP No creaming Operator Name
3 Months 40°C 100-200 nm -30 to -50 mV 10 cP No creaming Operator Name
Liposome and Emulsion Formulations Tags:Antioxidants in emulsions, API incorporation in emulsions, API incorporation in liposomes, Chemical stability testing liposomes, Cosmetic emulsion formulation, Emulsion droplet size analysis, Emulsion formulation SOP, Emulsion microbiological stability, Emulsion stability testing, Freeze-thaw stability testing, Heat-sensitive liposomes, High-shear mixing emulsions, Liposomal drug delivery SOP, Liposomal vaccines SOP, Liposome formulation SOP, Liposome particle size analysis, Liposome preparation procedure, Liposome size distribution, Liposome stability testing, Nanoemulsion SOP, Parenteral emulsion preparation, pH-responsive emulsions, Physical stability liposomes, Self-emulsifying drug delivery systems (SEDDS), Thin-film hydration liposomes

Post navigation

Previous Post: SOP for Incorporation of Stabilizers in Nanoparticle-Based Formulations
Next Post: SOP for Setup and Use of Fluid Bed Dryers

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version